Embracer Group (EMBRAC) Q3 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 25/26 earnings summary
12 Feb, 2026Executive summary
Q3 net sales were SEK 5,176 million, down 26% year-over-year and 8% organically, mainly due to divestments and a slow quarter for new releases, but results exceeded management expectations.
Adjusted EBIT was SEK 528 million, a 44% decrease year-over-year, but ahead of plan and improved over Q1 and Q2, with core IPs like Kingdom Come: Deliverance, Dead Island, and Tomb Raider driving outperformance.
Coffee Stain Group was spun off and reclassified as discontinued operations, impacting year-on-year comparisons and segment results.
Strategic focus sharpened on an IP-first approach, operational discipline, and targeted cost initiatives, including divestment of non-strategic businesses.
Free cash flow for the trailing twelve months was SEK -15 million, a significant improvement from SEK -399 million in the prior period.
Financial highlights
Net sales: SEK 5,176 million, impacted by SEK 900 million from divestments and SEK 400 million from FX effects.
Adjusted EBIT: SEK 528 million, with margin at 13%, showing sequential improvement.
Gross profit margin: 55%, down from 58% year-over-year, but up 3 points excluding divestments.
Free cash flow after working capital: SEK -75 million for the quarter, with TTM showing significant improvement.
Net cash position at quarter-end: SEK 2.9 billion, with available funds of SEK 5.8 billion.
Outlook and guidance
Adjusted EBIT forecast for FY 2025/26 is at least SEK 750 million, revised from SEK 1.0 billion due to the Coffee Stain Group spin-off; on a comparable basis, this is a modest upgrade.
Management sees upside potential in underlying business performance and expects a confident earnings inflection for next year, supported by a major in-house title and several mid-sized releases.
Long-term focus on increasing CapEx allocation to core IPs, targeting 80% over time (currently at 40%).
Latest events from Embracer Group
- Lean teams, strong IPs, and SEK 500m net cash drive growth and shareholder returns.EMBRAC
Coffee Stain CMD 20253 Feb 2026 - Sales and EBIT dropped, but cash flow and debt improved as spin-off plans progressed.EMBRAC
Q1 24/251 Feb 2026 - All proposals passed as 12% sales growth and a split into three listed entities were announced.EMBRAC
AGM 202420 Jan 2026 - Easybrain divestment and Asmodee spin-off will transform the balance sheet and outlook.EMBRAC
Q2 24/2514 Jan 2026 - Aims for 18%+ EBITDA margin and global IP leadership, driven by growth and sustainability.EMBRAC
Asmodee CMD 202413 Jan 2026 - 7% organic growth, strong cash flow, and major spin-offs mark a transformative Q3.EMBRAC
Q3 24/2527 Dec 2025 - Net sales fell 31% year-over-year as the group shifts to core IPs and prepares a major spin-off.EMBRAC
Q1 25/2623 Nov 2025 - Q4 organic growth, strong cash, and Coffee Stain spin-off drive future AAA pipeline.EMBRAC
Q4 24/2519 Nov 2025 - Q2 sales fell 19% with EBIT at SEK 109 million; full-year profit guidance is maintained.EMBRAC
Q2 25/2613 Nov 2025